Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities

New therapies are required to reduce myocardial infarct (MI) size and prevent the onset of heart failure in patients presenting with acute myocardial infarction (AMI), one of the leading causes of death and disability globally. In this regard, the immune cell response to AMI, which comprises an init...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cardiovasc Res
Asıl Yazarlar: Andreadou, Ioanna, Cabrera-Fuentes, Hector A, Devaux, Yvan, Frangogiannis, Nikolaos G, Frantz, Stefan, Guzik, Tomasz, Liehn, Elisa A, Gomes, Clarissa P C, Schulz, Rainer, Hausenloy, Derek J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2019
Konular:
Invited Spotlight Reviews
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6529904/
https://ncbi.nlm.nih.gov/pubmed/30825305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvz050
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller